Business Context and Reporting Period
This Form 6-K filing, dated August 12, 2020, serves as a Notice of Annual General Meeting (AGM) and Proxy Statement for Camtek Ltd., an Israeli company specializing in semiconductor test equipment. The AGM is scheduled for September 24, 2020. The filing details proposals for shareholder approval regarding board composition, executive compensation, indemnification, and auditor re-appointment. The company operates under a joint control structure involving Priortech Ltd. and Chroma ATE Inc.
Key Financial Metrics and Ownership
The filing does not provide current period revenue, profit, or cash flow data, as it is a governance notice rather than a financial results report. However, it references the audited consolidated financial statements for the year ended December 31, 2019, and provides the following specific financial and ownership data:
- Outstanding Shares: 39,149,395 ordinary shares as of July 31, 2020.
- CEO Equity Grant Value: Approximately $677,160 as of August 10, 2020 (based on 44,000 RSUs).
- Total 2020 Equity Scheme: 456,500 RSUs with a total value of $4.6 million (as of May 8, 2020), representing a 1.2% dilution effect.
- Auditor Fees (FY 2019): Total fees paid to Somekh Chaikin were $272,012, comprising $255,700 in audit fees and $16,312 in tax fees.
- Major Shareholders (as of July 31, 2020):
- Priortech Ltd.: 23.62% (9,250,189 shares)
- Chroma ATE Inc.: 19.96% (7,817,440 shares)
- Federated Hermes, Inc.: 5.10% (2,000,000 shares)
Material Changes and Governance Proposals
The filing outlines four primary proposals for shareholder action, reflecting material changes to corporate governance and compensation structures:
- Board Expansion: Election of Ms. Orit Stav as a new independent director. This is intended to eliminate a "personally-interested majority" on the Board regarding transactions with Chroma ATE Inc., ensuring compliance with Israeli Companies Law.
- CEO Compensation: Approval of a 2020 equity grant for CEO Rafi Amit consisting of 44,000 RSUs. The grant includes performance-based vesting (40%) tied to revenue targets relative to the semiconductor market and time-based vesting (60%).
- Indemnification Renewal: Re-approval of Indemnification and Exemption Letters for CEO Rafi Amit and Director Yotam Stern for a three-year term commencing November 12, 2020. The aggregate indemnification cap is set at 25% of shareholders' equity.
- Auditor Re-appointment: Re-appointment of Somekh Chaikin (KPMG International) as the independent auditor for the fiscal year ending December 31, 2020.
Outlook, Risks, and Contingencies
Meeting Format Contingency: The AGM is currently planned to be held in person at the company's offices in Migdal Ha'Emek, Israel. However, the company reserves the right to hold the meeting virtually if required by Israeli Ministry of Health COVID-19 restrictions. Any change in format will be announced via a subsequent Form 6-K.
Voting Requirements: Proposals regarding the CEO equity grant and indemnification letters require a "Disinterested Majority" vote under Israeli law. This means the majority of votes cast in favor must come from shareholders who do not have a controlling interest or personal interest in the proposal. The company notes that Priortech, Chroma, and their respective representatives (Messrs. Amit, Stern, and Huang) have personal interests and will not vote on these specific items.
Performance Metrics: The CEO's performance-based RSUs are tied to challenging revenue targets. The specific percentage targets are deemed commercially sensitive and are not disclosed in the filing.
Key Facts for Investor Verification
- Verify the final format of the AGM (in-person vs. virtual) by checking for subsequent Form 6-K filings prior to September 24, 2020.
- Confirm the specific revenue growth targets for the CEO's performance-based RSUs, as these are not disclosed in this document.
- Review the audited financial statements for the year ended December 31, 2019, referenced in the filing, to assess the baseline for the CEO's performance metrics.
- Note that the CEO equity grant represents approximately 215% of the CEO's annual base salary, which is within the company's compensation policy cap of 300%.
- Understand that the election of Ms. Orit Stav is a governance measure specifically designed to resolve a conflict of interest regarding the company's relationship with Chroma ATE Inc.